142
Participants
Start Date
April 30, 2008
Primary Completion Date
May 31, 2010
Study Completion Date
June 30, 2010
imexon in combination with gemcitabine
875 mg/m\^2 imexon IV + 1000 mg/m\^2 gemcitabine IV
imexon placebo + gemcitabine
imexon placebo IV + 1000 mg/m\^2 gemcitabine IV
Roswell Park Cancer Institute, Buffalo
University of Pittsburgh Cancer Institute, Pittsburgh
Medical Onc Assoc of Wyoming Valley, PC- US Oncology, Kingston
Associates in Hematology-Oncology P.C. US Oncology, Upland
Fox Chase Cancer Center, Philadelphia
Pottstown Memorial Medical Center, Pottstown
Reading Hospital Regional Medical Center, West Reading
Virginia Oncology Associates- US Oncology, Norfolk
Onc & Hematology Assoc. of Southern VA, Inc D.B.A. - US Oncology, Salem
Cancer Center of North Carolina- US Oncology, Raleigh
Peachtree Hematology and Oncology Consultants, Atlanta
Ocala Oncology Center- US Oncology, Ocala
Cancer Centers of Florida- US Oncology, Orlando
Birmingham Hematology and Oncology- US Oncology, Birmingham
Central Indiana Cancer Centers- US Oncology, Indianapolis
Northern Indiana Cancer Research Consortium, South Bend
Hope Center- US Oncology, Terre Haute
University of Michigan, Ann Arbor
University of Minnesota, Minneapolis
Sanford Clinic, Sioux Falls
Hematology Oncology Associates of Illinois- US Oncology, Chicago
Cancer Care & Hematolog Specialists of Chicagoland- US Oncology, Niles
Kansas City Cancer Center, LLC- US Oncology, Kansas City
Texas Cancer Center at Medical City- US Oncology, Dallas
Texas Oncology P.A. - Dallas- US Oncology, Dallas
Methodist Charlton Cancer Center - Texas Oncology- US Oncology, Dallas
Texas Oncology P.A.- Bedford- US Oncology, Bedford
Texoma Cancer Center- US Oncology, Wichita Falls
Scott and White Hospital and Clinics, Temple
Texas Oncology Cancer Care and Research Center- US Oncology, Waco
Mamie Mcfaddin Ward Cancer Center, Texas Oncology- US Oncology, Beaumont
Texas Oncology - Amarillo- US Oncology, Amarillo
Texas Oncology - Odessa- US Oncology, Odessa
Rocky Mountain Cancer Center- US Oncology, Denver
AZ Onc Associates D.B.A. Hematology Oncology- US Oncology, Tucson
Arizona Clinical Research Center, Tucson
Hematology Oncology Associates, Albuquerque
University of New Mexico, Albuquerque
New Mexico Cancer Care Associates- US Oncology, Santa Fe
University of New Mexico Cancer Center South, Las Cruces
Comprehensive Cancer Centers of Nevada- US Oncology, Las Vegas
Swedish Cancer Institute, Seattle
Northwest Cancer Specialists- US Oncology, Vancouver
Cancer Care Northwest- US Oncology, Spokane
University of Kentucky, Hematology/Oncology/BMT Clinical Research, Lexington
Lahey Clinic, Burlington
Hunterdon Regional Cancer Center, Flemington
Hematology Oncology Associates, Mount Holly
Lead Sponsor
AmpliMed Corporation
INDUSTRY